<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">12203</article-id><article-id pub-id-type="doi">10.7554/eLife.12203</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-49064"><name><surname>Kümper</surname><given-names>Sandra</given-names></name><aff><institution content-type="dept">Division of Cancer Biology</institution>, <institution>Institute of Cancer Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country><email>sandra.kuemper@icr.ac.uk</email></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-44644"><name><surname>Mardakheh</surname><given-names>Faraz K</given-names></name><aff><institution content-type="dept">Division of Cancer Biology</institution>, <institution>Institute of Cancer Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-44645"><name><surname>McCarthy</surname><given-names>Afshan</given-names></name><aff><institution content-type="dept">Division of Cancer Biology</institution>, <institution>Institute of Cancer Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-44646"><name><surname>Yeo</surname><given-names>Maggie</given-names></name><aff><institution content-type="dept">Division of Cancer Biology</institution>, <institution>Institute of Cancer Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-44647"><name><surname>Stamp</surname><given-names>Gordon W</given-names></name><aff><institution content-type="dept">Experimental Pathology Laboratory</institution>, <institution>Cancer Research UK London Research Institute</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-44648"><name><surname>Paul</surname><given-names>Angela</given-names></name><aff><institution content-type="dept">Division of Cancer Biology</institution>, <institution>Institute of Cancer Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-44649"><name><surname>Worboys</surname><given-names>Jonathan</given-names></name><aff><institution>Cancer Research UK Manchester Institute</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49065"><name><surname>Sadok</surname><given-names>Amine</given-names></name><aff><institution content-type="dept">Division of Cancer Biology</institution>, <institution>Institute of Cancer Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49066"><name><surname>Jørgensen</surname><given-names>Claus</given-names></name><aff><institution>Cancer Research UK Manchester Institute</institution>, <addr-line><named-content content-type="city">Manchester</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49067"><name><surname>Guichard</surname><given-names>Sabrina</given-names></name><aff><institution content-type="dept">Division of Cancer Biology</institution>, <institution>Institute of Cancer Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-44658"><name><surname>Marshall</surname><given-names>Christopher J</given-names></name><aff><institution content-type="dept">Division of Cancer Biology</institution>, <institution>Institute of Cancer Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1072"><name><surname>Davis</surname><given-names>Roger</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute &amp; University of Massachusetts Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>14</day><month>01</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e12203</elocation-id><supplementary-material><ext-link xlink:href="elife-12203-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>09</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>13</day><month>01</month><year>2016</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><abstract><p>Rho-associated kinases 1 and 2 (ROCK1/2) are Rho-GTPase effectors that control key aspects of the actin cytoskeleton, but their role in proliferation and cancer initiation or progression is not known. Here we provide evidence that ROCK1 and ROCK2 act redundantly to maintain actomyosin contractility and cell proliferation and that their loss leads to cell-cycle arrest and cellular senescence. This phenotype arises from down-regulation of the essential cell-cycle proteins CyclinA, CKS1 and CDK1. Accordingly, while loss of either <italic>Rock1</italic> or <italic>Rock2</italic> had no negative impact on tumorigenesis in mouse models of non-small cell lung cancer and melanoma, loss of both blocked tumor formation, as no tumors arise in which both <italic>Rock1</italic> and <italic>Rock2</italic> have been genetically deleted. Our results reveal an indispensable role for ROCK, yet redundant role for isoforms 1 and 2, in cell cycle progression and tumorigenesis, possibly through the maintenance of cellular contractility.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal procedures were approved by the Animal Ethics Committee of the Institute of Cancer Research in accordance with National Home Office regulations under the Animals (Scientific Procedures) Act 1986. The date of approval of the current project license under which this work was carried out was the 07/09/13.</p></fn></fn-group></back></article>